This conference will provide 6 CE/CME credits hours
Register today for only $129!

As we better understand the acute challenges of managing the COVID-19 pandemic, it is the lingering effects on COVID-19 survivors that healthcare providers are increasingly beginning to treat. Initially viewed as a respiratory disease, it is now clearer that many organ systems are affected due to a systemic inflammatory response. Many COVID-19 survivors have sustained prolonged periods of sedation and immobilization, putting them at increased risk of myopathy and polyneuropathy. Emerging reports of neurological sequelae include nerve pain, confusion, headache, anosmia, and chronic fatigue. This course will shed light on some of these emerging symptoms and potential treatment solutions.

Faculty: Michael M. Bottros, MD

UAN: 0530-0000-22-059-L01-P

Rx Hours: 0.0

Many providers are unfamiliar with the information surrounding ALS and there are many knowledge gaps surrounding this disease state. Arming providers with an expansive understanding of this disease state is extremely important. This course will provide healthcare providers with clinical updates and tools that will ensure that their patients receive the best possible care available.

Supported by an educational grant from Mitsubishi.

Faculty: Xiaoyan Li, MD, PhD

UAN: 0530-0000-22-089-L01-P

Rx hours: 0.1

This course will provide a summary of the best-evidence treatments for Parkinson’s disease, drug-induced movement disorders, and a select group of other movement disorders. Symptomatic and disease modifying therapies will be discussed and evidence-based approaches to achieve the best treatment outcomes in Parkinson’s disease and other movement disorder conditions will be reviewed. The motor complications of Parkinson’s disease will be described including strategies for managing on-off dopamine medication fluctuations. Finally, a model for optimal care including a collaborative care team will be discussed.

Faculty: Gregory Pontone, MD, MHS

UAN: 0530-0000-22-061-L01-P

Rx hours: 0.0

Breaks & Exhibits

*Not certified for credit.

Difficulty with medication adherence is common in bipolar disorder and results in significant disability and suffering. There are many potential barriers to medication adherence. These include external factors such as complex medication regimens, side effects, and issues with access to care, as well as patient specific factors such as sociodemographic issues, maladaptive beliefs about the illness, and the severity and nature of an individual’s bipolar symptoms. This session will provide an overview of these barriers and practical strategies for addressing some of them in clinical practice, with a focus on crafting an effective and tolerable medication regimen for our patients. In particular, the use of long acting injectable (LAI) treatments to enhance medication adherence in bipolar disorder will be explored.

Faculty: Sanjai Rao, MD, DFAPA

UAN: 0530-0000-22-058-L01-P

Rx hours: 0.6

Breaks & Exhibits

Central poststroke pain (CPSP) is a neuropathic pain disorder frequently described as burning pain associated with allodynia and hyperalgesia over affected regions of the body. The underlying mechanisms are not well understood. It has been suggested that stroke associated loss of inhibitory neurons in the spinothalamic tract causes disinhibition of thalamic neurons, which generate ectopic nociceptive action potentials responsible for the pain experience. However, data suggests that pain is dependent on the peripheral afferent input and may be mediated by misinterpretation of sensory input. In this course, we review the pathophysiology, clinical presentation, and symptoms of CPSP. Recent findings may also shed light about future targets for treatment.

Faculty: Michael M. Bottros, MD

UAN: 0530-0000-22-062-L01-P

Rx hours: 0.0

This course will provide a summary of the most common clinical presentations of Parkinson’s disease, essential tremor, and multiple sclerosis. Strategies for efficient differential diagnosis of each disease will be reviewed. Existing or emerging biomarkers will be discussed. Finally, the talk will conclude with a brief outline of general treatment strategies and emerging trends and how to proceed if uncertainty remains in the differential diagnosis.

Faculty: Gregory Pontone, MD, MHS

UAN: 0530-0000-22-060-L01-P

Rx hours: 0.0